In a recent article in Harvard Business Review, “Real Innovation Requires More Than an R&D Budget,” Dr. Gina O’Connor makes the case for having three capabilities for any innovation initiative: Discovery, Incubation, and Acceleration (DIA), in which R&D is only a portion of Discovery. In my experience with multiple companies, Discovery was allowed as long as Senior Management didn’t know about it, Incubation had a zero-dollar budget, and Acceleration only happened by chance. But since a few ideas made it out of the so-called “innovation pipeline”, there was the appearance that innovation was working. And I admit, the few ideas that made it into products were pretty good. Ours was a haphazard process at best, however. O’Connor further attempts to connect R&D to market value, which is admittedly difficult for those that have tried. It is nearly impossible from a third-party perspective, using only publicly available data. She asserts that the best third-party correlation occurs when there are dedicated innovation teams, and when the company goes public with their innovation efforts. But from my experience, connecting R&D to market value is much more complex.
Recent Posts
- Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines ‘Ground’ for IPR Estoppel Statute
- PTAB Designates as Informative Stewart Decision on Discretion to Institute in Context of Parallel District Court Litigation
- Judge Hughes Again Calls Out CAFC’s Overly Rigid Article III Analysis for Pharmaceutical Cases
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges
- The USPTO Should Reintroduce the AFCP Program—Now